NO180304C - Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion

Info

Publication number
NO180304C
NO180304C NO914710A NO914710A NO180304C NO 180304 C NO180304 C NO 180304C NO 914710 A NO914710 A NO 914710A NO 914710 A NO914710 A NO 914710A NO 180304 C NO180304 C NO 180304C
Authority
NO
Norway
Prior art keywords
beta
preparation
therapeutically active
analogous process
compounds
Prior art date
Application number
NO914710A
Other languages
English (en)
Other versions
NO180304B (no
NO914710D0 (no
NO914710L (no
Inventor
John O'neal Johnston
Norton Paul Peet
Joseph Paul Burkhart
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO914710D0 publication Critical patent/NO914710D0/no
Publication of NO914710L publication Critical patent/NO914710L/no
Publication of NO180304B publication Critical patent/NO180304B/no
Publication of NO180304C publication Critical patent/NO180304C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
NO914710A 1990-11-30 1991-11-29 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion NO180304C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/621,184 US5166201A (en) 1990-11-30 1990-11-30 2β,19-ethylene bridged steroids as aromatase inhibitors

Publications (4)

Publication Number Publication Date
NO914710D0 NO914710D0 (no) 1991-11-29
NO914710L NO914710L (no) 1992-06-01
NO180304B NO180304B (no) 1996-12-16
NO180304C true NO180304C (no) 1997-04-02

Family

ID=24489093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914710A NO180304C (no) 1990-11-30 1991-11-29 Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2<beta>,19-(ethylen)androst-4-en-3,17-dion

Country Status (20)

Country Link
US (1) US5166201A (no)
EP (1) EP0488383B1 (no)
JP (1) JP3143876B2 (no)
KR (1) KR100190776B1 (no)
CN (1) CN1033975C (no)
AT (1) ATE142639T1 (no)
AU (1) AU635444B2 (no)
CA (1) CA2056638C (no)
DE (1) DE69122048T2 (no)
DK (1) DK0488383T3 (no)
ES (1) ES2094183T3 (no)
FI (1) FI102073B (no)
GR (1) GR3021981T3 (no)
HU (1) HU210830B (no)
IE (1) IE914168A1 (no)
IL (1) IL100196A (no)
NO (1) NO180304C (no)
NZ (1) NZ240738A (no)
PT (1) PT99661B (no)
ZA (1) ZA919296B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510862A1 (de) * 1995-03-16 1996-09-19 Schering Ag Verwendung von Antiestrogenen zur männlichen Fertilitätskontrolle
US6372712B1 (en) 1998-05-22 2002-04-16 The Board Of Trustees Of The Leland Stanford Jr. University Synthetic bifunctional molecules containing a drug moiety and presenter protein ligand
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
WO2007035716A2 (en) 2005-09-16 2007-03-29 Raptor Pharmaceutical Inc. Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
PT3395372T (pt) 2009-02-20 2022-05-05 Enhanx Biopharm Inc Sistema de entrega de medicamentos à base de glutationa
KR20180114970A (ko) 2009-05-06 2018-10-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627756A (en) * 1970-04-23 1971-12-14 Searle & Co N-dialkylaminoalkyl-n-(2{62 ,19-epoxy-5{60 -androstan-17{62 -yl)amines/formamides and 3{60 -halo derivatives thereof
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
US4882322A (en) * 1988-10-27 1989-11-21 Merrell Dow Pharmaceuticals Inc. 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Also Published As

Publication number Publication date
CN1033975C (zh) 1997-02-05
FI915623A0 (fi) 1991-11-28
AU635444B2 (en) 1993-03-18
DK0488383T3 (da) 1996-09-30
FI102073B1 (fi) 1998-10-15
NO180304B (no) 1996-12-16
CA2056638A1 (en) 1992-05-31
ZA919296B (en) 1992-08-26
NO914710D0 (no) 1991-11-29
FI102073B (fi) 1998-10-15
PT99661B (pt) 1999-05-31
JP3143876B2 (ja) 2001-03-07
US5166201A (en) 1992-11-24
EP0488383A1 (en) 1992-06-03
ATE142639T1 (de) 1996-09-15
HU913739D0 (en) 1992-02-28
HU210830B (en) 1995-08-28
NO914710L (no) 1992-06-01
IL100196A0 (en) 1992-08-18
DE69122048T2 (de) 1997-02-20
FI915623A (fi) 1992-05-31
KR920009842A (ko) 1992-06-25
IL100196A (en) 1996-03-31
NZ240738A (en) 1993-11-25
KR100190776B1 (ko) 1999-06-01
HUT59937A (en) 1992-07-28
ES2094183T3 (es) 1997-01-16
PT99661A (pt) 1992-10-30
IE914168A1 (en) 1992-06-03
CA2056638C (en) 2002-03-05
GR3021981T3 (en) 1997-03-31
CN1061974A (zh) 1992-06-17
DE69122048D1 (de) 1996-10-17
AU8812891A (en) 1992-06-04
EP0488383B1 (en) 1996-09-11
JPH04290898A (ja) 1992-10-15

Similar Documents

Publication Publication Date Title
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
NO20002676L (no) Androgene steroidforbindelser og en fremgangsmÕte for fremstilling og anvendelse av samme
FI884087A0 (fi) Foerfarande foer framstaellning av metylenderivat av androsta-1,4-dien-3,17-dion.
NO180304C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt 2&lt;beta&gt;,19-(ethylen)androst-4-en-3,17-dion
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
AU641686B2 (en) Benzanilides
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
NO302123B1 (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2&lt;beta&gt;,19-metylenaminobroede steroider
NO911896D0 (no) Umettede polyesterharpikser og fremgangsmaate for fremstilling av harpiksene.
ES2131824T3 (es) Compuestos de piridina sustituidos en 3 y derivados de los mismos como herbicidas.
NO174962C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,5,6,7-tetranor-4,8-inter-m-fenylen PGI2-derivater
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
FR2312244A1 (fr) Nouvelles 2-imidazolines et leur utilisation comme agents hypoglycemiques
AU553765B2 (en) Biologically active heterocyclic hydroximidates and thiolhydroximidates and carbamate ester derivatives thereof
NZ237559A (en) Halogenoethyl steroid derivatives and pharmaceutical compositions
WO1989005809A1 (en) Imidazo- and pyrimido-quinoline, naphthyridine and pyridopyrazine compounds

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2001